MEFOX
Price
$81.97
Change
-$0.95 (-1.15%)
Updated
Jul 13 closing price
Net Assets
219.25M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

MEFOX vs VSTSX

MEFOX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
MEFOX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEFOX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. MEFOX (219M). VSTSX pays higher dividends than MEFOX: VSTSX (1.07) vs MEFOX (0.14). MEFOX was incepted earlier than VSTSX: MEFOX (27 years) vs VSTSX (10 years). MEFOX (1.06) is less costly to investors than VSTSX (0.01). VSTSX is a more actively managed with annual turnover of: 3.00 vs. MEFOX (2.00). MEFOX has a lower initial minimum investment than VSTSX: MEFOX (5000) vs VSTSX (5000000000). MEFOX annual gain was more profitable for investors over the last year : 28.32 vs. VSTSX (21.48). MEFOX return over 5 years is better than : 97.26 vs. VSTSX (66.56).
MEFOXVSTSXMEFOX / VSTSX
Total Expense Ratio1.010.0110,100%
Annual Report Gross Expense Ratio1.060.0110,600%
Fund Existence27 years10 years-
Gain YTD13.72911.205123%
Front LoadN/AN/A-
Min. Initial Investment500050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets219M2.3T0%
Annual Yield % from dividends0.141.0713%
Returns for 1 year28.3221.48132%
Returns for 3 years89.1067.06133%
Returns for 5 years97.2666.56146%
Returns for 10 years326.96239.53137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I